BIOMAT Database Logo BIOMAT Database Logo

CDK regulators-Cell cycle progression or apoptosis-Scenarios in normal cells and cancerous cells. 2023

Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Laboratory of Integrative Genomics, Department of Integrative Biology, School of Bio Sciences and Technology, Vellore Institute of Technology (VIT), Vellore, Tamil Nadu, India.

Serine/threonine kinases called cyclin-dependent kinases (CDKs) interact with cyclins and CDK inhibitors (CKIs) to control the catalytic activity. CDKs are essential controllers of RNA transcription and cell cycle advancement. The ubiquitous overactivity of the cell cycle CDKs is caused by a number of genetic and epigenetic processes in human cancer, and their suppression can result in both cell cycle arrest and apoptosis. This review focused on CDKs, describing their kinase activity, their role in phosphorylation inhibition, and CDK inhibitory proteins (CIP/KIP, INK 4, RPIC). We next compared the role of different CDKs, mainly p21, p27, p57, p16, p15, p18, and p19, in the cell cycle and apoptosis in cancer cells with respect to normal cells. The current work also draws attention to the use of CDKIs as therapeutics, overcoming the pharmacokinetic barriers of pan-CDK inhibitors, analyze new chemical classes that are effective at attacking the CDKs that control the cell cycle (cdk4/6 or cdk2). It also discusses CDKI's drawbacks and its combination therapy against cancer patients. These findings collectively demonstrate the complexity of cancer cell cycles and the need for targeted therapeutic intervention. In order to slow the progression of the disease or enhance clinical outcomes, new medicines may be discovered by researching the relationship between cell death and cell proliferation.

UI MeSH Term Description Entries
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D050759 Cyclin-Dependent Kinase Inhibitor p21 A cyclin-dependent kinase inhibitor that mediates TUMOR SUPPRESSOR PROTEIN P53-dependent CELL CYCLE arrest. p21 interacts with a range of CYCLIN-DEPENDENT KINASES and associates with PROLIFERATING CELL NUCLEAR ANTIGEN and CASPASE 3. CDK2-Associated Protein 20 kDa,CDKN1 Protein,CDKN1A Protein,Cdk-Interacting Protein 1,Cdk2 Inhibitor Protein,Cell Cycle Regulator p21,Cyclin Kinase Inhibitor p21,Cyclin-Dependent Kinase Inhibitor 1A Protein,Senescent Cell-Derived Inhibitor Protein 1,p21 Cell Cycle Regulator,p21 Cyclin Kinase Inhibitor,CDK2 Associated Protein 20 kDa,Cdk Interacting Protein 1,Cyclin Dependent Kinase Inhibitor 1A Protein,Cyclin Dependent Kinase Inhibitor p21,Senescent Cell Derived Inhibitor Protein 1
D018797 Cell Cycle Proteins Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and PHOSPHOPROTEIN PHOSPHATASES as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS. Cell Division Cycle Proteins,Cell-Cycle Regulatory Proteins,cdc Proteins,Cell Cycle Regulatory Proteins
D018844 Cyclin-Dependent Kinases Protein kinases that control cell cycle progression in all eukaryotes and require physical association with CYCLINS to achieve full enzymatic activity. Cyclin-dependent kinases are regulated by phosphorylation and dephosphorylation events. Cyclin-Dependent Kinase,Cyclin-Dependent Protein Kinase,cdk Proteins,Cyclin-Dependent Protein Kinases,Cyclin Dependent Kinase,Cyclin Dependent Kinases,Cyclin Dependent Protein Kinase,Cyclin Dependent Protein Kinases,Kinase, Cyclin-Dependent,Kinase, Cyclin-Dependent Protein,Protein Kinase, Cyclin-Dependent

Related Publications

Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
CDK inhibitors: cell cycle regulators and beyond.
February 2008, Developmental cell,
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Cell cycle regulators in the keratinocyte (cyclin-cdk).
February 1995, Experimental dermatology,
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Emerging links between CDK cell cycle regulators and Wnt signaling.
August 2010, Trends in cell biology,
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
CDK inhibitors: cell cycle arrest versus apoptosis.
January 2002, Cell cycle (Georgetown, Tex.),
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Subcellular and cell-cycle expression profiles of CDK-inhibitors in normal differentiating myeloid cells.
May 1999, Blood,
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Endothelial nitric oxide synthase deficiency influences normal cell cycle progression and apoptosis in trabecular meshwork cells.
January 2016, International journal of ophthalmology,
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells.
July 2011, Molecular nutrition & food research,
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Cdk activity couples epigenetic centromere inheritance to cell cycle progression.
January 2012, Developmental cell,
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division.
January 2001, Protoplasma,
Nilmani, and Maria D'costa, and Anusha Bothe, and Soumik Das, and S Udhaya Kumar, and R Gnanasambandan, and C George Priya Doss
Radiation-induced apoptosis and cell cycle progression in Jurkat T cells.
September 1999, Radiation research,
Copied contents to your clipboard!